88 results
Page 3 of 5
8-K
EX-2.1
o12hijoqyhvkz5e4q
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-2.1
dcd7sxs4gb1jyjve9u26
7 May 21
Business combination disclosure
7:08am
425
EX-10.1
z0rqpilcn1 imb6
7 May 21
Business combination disclosure
7:08am
8-K
zc6a x9fi
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-3.1
dsnf9j
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.1
riqiv 95cfld
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.2
1zhd m477
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
7ojrqods2mxdawz5
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
8-K
EX-99.1
dfmpae
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
DEFA14A
i0el97jb5xi yr2a2
11 Sep 20
Additional proxy soliciting materials
7:00am
DEF 14A
3iqr8iwce1g1znf
9 Sep 20
Definitive proxy
4:00pm
PRE 14A
8gbhbtdl6zmt6c8
10 Aug 20
Preliminary proxy
12:00am
8-K
EX-99.1
evrq5xrg jf159td7
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
8-K
okb pxvog0v
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
EX-99.1
ftzpk btys
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.1
94cf8g
28 Aug 19
Current report (foreign)
4:05pm
6-K
EX-99.1
nkbg5sff3a9f243
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
ju1g286z5o hf1
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
j1g9pnzvm4oivbol1
14 Nov 18
Current report (foreign)
7:00am